Insider · CIK 0001722061

Gerngross Tillman U.

Reports to the SEC for 3 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001722061

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-14	ALECAlector, Inc.A Award	Director	AAward	+26.3K sh	—	—	2,644,319
2023-06-14	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.4K sh	—	—	12,360
2022-06-16	ALECAlector, Inc.A Award	Director	AAward	+9,459 sh	—	—	2,618,069
2022-06-16	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+18.9K sh	—	—	18,918
2022-01-30	IVVDInvivyd, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer, 10% Owner	AAward	+175K sh	—	—	175,000
2021-08-10	IVVDInvivyd, Inc.C Conversion	Director, Chief Executive Officer, 10% Owner	CConversion	+25.9M sh	—	—	27,845,995
2021-08-10	IVVDInvivyd, Inc. · Series A Preferred StockC Conversion	Director, Chief Executive Officer, 10% Owner	CConversion	−5M sh	—	—	0
2021-08-10	IVVDInvivyd, Inc. · Series B Preferred StockC Conversion	Director, Chief Executive Officer, 10% Owner	CConversion	−44.1K sh	—	—	0
2021-08-10	IVVDInvivyd, Inc. · Series C Preferred StockC Conversion	Director, Chief Executive Officer, 10% Owner	CConversion	−128K sh	—	—	0
2021-06-17	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25.7K sh	—	—	25,709
2020-05-11	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+19.3K sh	—	—	19,274
2019-05-10	ALECAlector, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2019-02-11	ALECAlector, Inc.C Conversion	Director	CConversion	+375K sh	—	—	2,555,850
2019-02-11	ALECAlector, Inc.C Conversion	Director	CConversion	+52.8K sh	—	—	2,608,610
2019-02-11	ALECAlector, Inc. · Series C Preferred StockC Conversion	Director	CConversion	−375K sh	—	—	0
2019-02-11	ALECAlector, Inc. · Series E Preferred StockC Conversion	Director	CConversion	−52.8K sh	—	—	0
2018-06-05	XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2017-11-20	XFORX4 Pharmaceuticals, IncC Conversion	Director	CConversion	+90.3K sh	—	—	192,821
2017-11-20	XFORX4 Pharmaceuticals, IncP Purchase	Director	PPurchase	+200K sh	$10.00	+$2M	392,821
2017-11-20	XFORX4 Pharmaceuticals, Inc · Series D Convertible Preferred StockC Conversion	Director	CConversion	−308K sh	—	—	0
2017-11-15	XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2017-11-15	XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award	Director	AAward	+7,324 sh	—	—	7,324

Recent filings

Accepted (ET)
Jun 154
Gerngross Tillman U.0000950170-23-028275
SEC(opens sec.gov)
Jun 214
Gerngross Tillman U.0001209191-22-038538
SEC(opens sec.gov)
Feb 14
Gerngross Tillman U.0001209191-22-006022
SEC(opens sec.gov)
Aug 124
Gerngross Tillman U.0001209191-21-051296
SEC(opens sec.gov)
Jun 224
Gerngross Tillman U.0001209191-21-042410
SEC(opens sec.gov)
May 134
Gerngross Tillman U.0001209191-20-028986
SEC(opens sec.gov)
May 144
Gerngross Tillman U.0001209191-19-029740
SEC(opens sec.gov)
Feb 114
Gerngross Tillman U.0001209191-19-009119
SEC(opens sec.gov)
Jun 74
Gerngross Tillman U.0001209191-18-036337
SEC(opens sec.gov)
Mar 54/A
Gerngross Tillman U.0001209191-18-016569
SEC(opens sec.gov)
Dec 14
Gerngross Tillman U.0000899243-17-027831
SEC(opens sec.gov)
Nov 204
Gerngross Tillman U.0000899243-17-027004
SEC(opens sec.gov)

Companies

Address

C/O ARSANIS, INC. 890 WINTER STREET, SUITE 230

WALTHAM, MA, 02451